Publicaciones en colaboración con investigadores/as de Université Catholique de Louvain (13)

2022

  1. IMI2-PainCare-BioPain-RCT1: study protocol for a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by peripheral nerve excitability testing (NET)

    Trials, Vol. 23, Núm. 1

  2. IMI2-PainCare-BioPain-RCT2 protocol: a randomized, double-blind, placebo-controlled, crossover, multicenter trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by non-invasive neurophysiological measurements of human spinal cord and brainstem activity

    Trials, Vol. 23, Núm. 1

  3. Pharmacological Probes to Validate Biomarkers for Analgesic Drug Development

    International Journal of Molecular Sciences, Vol. 23, Núm. 15

2021

  1. IMI2-PainCare-BioPain-RCT3: a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by electroencephalography (EEG)

    Trials, Vol. 22, Núm. 1

2020

  1. Reporting Guidelines, Review of Methodological Standards, and Challenges Toward Harmonization in Bone Marrow Adiposity Research. Report of the Methodologies Working Group of the International Bone Marrow Adiposity Society

    Frontiers in Endocrinology, Vol. 11

2016

  1. Cyclosporine A-loaded lipid nanoparticles in inflammatory bowel disease

    International Journal of Pharmaceutics, Vol. 503, Núm. 1-2, pp. 196-198

  2. Reformulating cyclosporine A (CsA): More than just a life cycle management strategy

    Journal of Controlled Release, Vol. 225, pp. 269-282

2014

  1. Vascular endothelial growth factor-loaded injectable hydrogel enhances plasticity in the injured spinal cord

    Journal of Biomedical Materials Research - Part A, Vol. 102, Núm. 7, pp. 2345-2355

2013

  1. Injectable alginate hydrogel loaded with GDNF promotes functional recovery in a hemisection model of spinal cord injury

    International Journal of Pharmaceutics, Vol. 455, Núm. 1-2, pp. 148-158

2012

  1. Brain drug delivery systems for neurodegenerative disorders

    Current Pharmaceutical Biotechnology, Vol. 13, Núm. 12, pp. 2388-2402

  2. Cellular pharmacokinetics and intracellular activity against Listeria monocytogenes and Staphylococcus aureus of chemically modified and nanoencapsulated gentamicin

    Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 9, pp. 2158-2164

2011

  1. In vitro and in vivo efficacy of edelfosine-loaded lipid nanoparticles against glioma

    Journal of Controlled Release, Vol. 156, Núm. 3, pp. 421-426

2010

  1. Incorporating physiological and biochemical mechanisms into pharmacokinetic-pharmacodynamic models: A conceptual framework

    Basic and Clinical Pharmacology and Toxicology